title: A Dictyostelium secreted factor requires a PTEN-like phosphatase to slow proliferation and induce chemorepulsion.
abstract: In Dictyostelium discoideum, AprA and CfaD are secreted proteins that inhibit cell proliferation. We found that the proliferation of cells lacking CnrN, a phosphatase and tensin homolog (PTEN)-like phosphatase, is not inhibited by exogenous AprA and is increased by exogenous CfaD. The expression of CnrN in cnrN cells partially rescues these altered sensitivities, suggesting that CnrN is necessary for the ability of AprA and CfaD to inhibit proliferation. Cells lacking CnrN accumulate normal levels of AprA and CfaD. Like cells lacking AprA and CfaD, cnrN cells proliferate faster and reach a higher maximum cell density than wild type cells, tend to be multinucleate, accumulate normal levels of mass and protein per nucleus, and form less viable spores. When cnrN cells expressing myc-tagged CnrN are stimulated with a mixture of rAprA and rCfaD, levels of membrane-associated myc-CnrN increase. AprA also causes chemorepulsion of Dictyostelium cells, and CnrN is required for this process. Combined, these results suggest that CnrN functions in a signal transduction pathway downstream of AprA and CfaD mediating some, but not all, of the effects of AprA and CfaD.
authors.affiliation: Department of Biology, Texas A&M University, College Station, TX, USA.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Herlihy
authors.forename: Yitai
authors.initials: Y
authors.lastname: Tang
authors.forename: Richard H
authors.initials: RH
authors.lastname: Gomer
mesh_terms: D002452:Cell Count; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D049109:Cell Proliferation / Q000187:drug effects; D002633:Chemotaxis / Q000235:genetics*; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004023:Dictyostelium / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D005786:Gene Expression Regulation; D051059:PTEN Phosphohydrolase / Q000172:deficiency / Q000235:genetics*; D015800:Protozoan Proteins / Q000235:genetics* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D033761:Spores, Protozoan / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*
chemical_list: D017077:Culture Media, Conditioned; D015800:Protozoan Proteins; D011993:Recombinant Fusion Proteins; D051059:PTEN Phosphohydrolase
references.citation: Curr Biol. 2007 May 1;17(9):813-7
references.pmid: 17462897
references.citation: J Cell Sci. 2008 Aug 1;121(Pt 15):2473-80
references.pmid: 18611962
references.citation: Annu Rev Cell Dev Biol. 2004;20:223-53
references.pmid: 15473840
references.citation: Eukaryot Cell. 2011 Apr;10(4):494-501
references.pmid: 21278229
references.citation: Curr Biol. 1997 Apr 1;7(4):261-9
references.pmid: 9094314
references.citation: Mol Cell Biol. 1998 Oct;18(10):5699-711
references.pmid: 9742087
references.citation: Commun Integr Biol. 2008;1(2):185-7
references.pmid: 19704889
references.citation: J Biol Chem. 2005 Feb 18;280(7):5581-7
references.pmid: 15583002
references.citation: J Cell Biol. 1997 Feb 10;136(3):633-47
references.pmid: 9024693
references.citation: Genes Dev. 1999 Aug 1;13(15):1960-9
references.pmid: 10444594
references.citation: Cancer Res. 1998 Nov 15;58(22):5002-8
references.pmid: 9823298
references.citation: Dev Cell. 2003 Feb;4(2):143-4
references.pmid: 12586054
references.citation: Mol Cell Biochem. 2003 Nov;253(1-2):241-6
references.pmid: 14619975
references.citation: BMC Biochem. 2009 Feb 02;10:4
references.pmid: 19187549
references.citation: PLoS One. 2010 Dec 14;5(12):e15309
references.pmid: 21179457
references.citation: J Biol Chem. 2004 Apr 16;279(16):16606-13
references.pmid: 14764604
references.citation: Mol Biol Cell. 2003 May;14(5):1913-22
references.pmid: 12802064
references.citation: Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10990-5
references.pmid: 22711818
references.citation: Nat Rev Mol Cell Biol. 2001 Jan;2(1):48-54
references.pmid: 11413465
references.citation: J Muscle Res Cell Motil. 2002;23(7-8):809-15
references.pmid: 12952079
references.citation: Annu Rev Cell Dev Biol. 2004;20:61-86
references.pmid: 15473835
references.citation: Oncogene. 1999 Dec 9;18(52):7462-8
references.pmid: 10602505
references.citation: J Cell Biol. 2004 Nov 8;167(3):505-18
references.pmid: 15534002
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5
references.pmid: 10200246
references.citation: Dev Biol. 2004 Sep 15;273(2):175-84
references.pmid: 15328005
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7491-6
references.pmid: 12808147
references.citation: Eukaryot Cell. 2008 Oct;7(10):1758-70
references.pmid: 18676953
references.citation: J Biol Chem. 1997 Dec 12;272(50):31515-24
references.pmid: 9395488
references.citation: Cell. 2002 May 31;109(5):599-610
references.pmid: 12062103
references.citation: Cancer Res. 1999 Nov 15;59(22):5808-14
references.pmid: 10582703
references.citation: J Cell Sci. 2007 Aug 1;120(Pt 15):2517-31
references.pmid: 17623773
references.citation: Cell. 1995 Jun 2;81(5):727-36
references.pmid: 7774014
references.citation: J Cell Biol. 2001 May 14;153(4):795-810
references.pmid: 11352940
references.citation: Development. 2005 Oct;132(20):4553-62
references.pmid: 16176950
references.citation: BMC Biol. 2009 Jul 27;7:44
references.pmid: 19635129
references.citation: Eukaryot Cell. 2010 Oct;9(10):1557-65
references.pmid: 20709790
references.citation: Oncogene. 2008 Sep 18;27(41):5464-76
references.pmid: 18794881
references.citation: PLoS One. 2011;6(7):e21765
references.pmid: 21760904
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S266-71
references.pmid: 19033211